Alzheimer’s blood test validated with help from UW–Madison data
The first blood plasma test to identify hallmarks of Alzheimer’s disease was cleared in May by the U.S. Food and Drug Administration (FDA), and University of Wisconsin researchers provided a portion of the samples used in the clinical validation test.
Q&A: Daniel Buckland on space medicine and medical technology
A space medicine fellowship, robots in the emergency room, and machine learning tools to improve clinical workflow are among the innovations Dr. Daniel Buckland, an associate professor in the BerbeeWalsh Department of Emergency Medicine, intends to explore within the University of Wisconsin School of Medicine and Public Health and UW’s College of Engineering, where he holds an affiliate governance appointment.
Schwarze named to National Academy of Medicine
Dr. Margaret “Gretchen” Schwarze, professor of surgery at the University of Wisconsin School of Medicine and Public Health, was recently elected as a member of the National Academy of Medicine for her pioneering work that has transformed how surgeons communicate with patients about major treatment decisions and informed consent for surgery.
An early roadmap to preventing a devastating childhood brain cancer
Stopping genetic mutations that cause a rare but aggressive brain tumor in children may be the key to preventing the cancer’s development in the first place, according to researchers in the UW School of Medicine and Public Health.
Cell therapy for Parkinson’s shows promise
Parkinson’s patients are receiving a new investigational treatment thanks to groundbreaking research by Dr. Marina Emborg, a professor of medical physics in the University of Wisconsin School of Medicine and Public Health.
UW–Madison to lead nation in boron neutron capture therapy for cancer
The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy (BNCT) center in the United States.
Q&A: Jacques Galipeau on cell therapies to cure disease
Dr. Jacques Galipeau is the associate dean for therapeutics development and the director of the Program for Advanced Cell Therapy (PACT), a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health that aims to bring innovative cell therapies to patients. He is also a practicing hematologist, treating patients with blood clot disorders, anemia, and other diseases and conditions.
James Dahlberg receives American Innovator Award
James Dahlberg, a professor emeritus of biomolecular chemistry whose research led to a widely accessible colon cancer screening test, received the American Innovator Award from the Bayh-Dole coalition in June.
World Breast Cancer Research Day
World Breast Cancer Research Day is celebrated on the 18th day of the eighth month of the year — a reference to the one in eight women and one in 833 men who will be diagnosed with breast cancer in their lifetimes. The day is intended to amplify the urgency of preventing disease and finding cures, as well as shine a light on critical research, including studies supported by federal funding.
Freeing kidney transplant patients from daily anti-rejection medications
Kidney transplant patients are embracing a new chapter of life, thanks to a groundbreaking clinical trial that eliminates the need for a lifelong regimen of anti-rejection drugs, which can cause serious side effects.
Training medical students for rural practice
